![Leonhard Schneider MD](https://res.cloudinary.com/els-assets/image/upload/f_auto,w_120,c_thumb,ar_1:1,g_face/r_max,bo_2px_solid_rgb:d3d3d37F/practice-update/remote-media/contentimage/44876.jpg)
Leonhard M. Schneider MD
Interventional Cardiologist and Imager, Department of Cardiology, University Heart Center Ulm, Ulm, GermanyLeonhard Schneider started as an interventional echocardiographeur in 2017 and since then expedited the development of mitral and tricuspid therapies by participating in numerous trials and establishing own research. In 2020 he joined the interventional side and expanded his valve portfolio to TAVR as well as percutaneous mitral and tricuspid replacement.
Disclosures
Edwards (proctoring, speaker honoraria and research collaboration)
Abbott (proctoring and speaker honoraria), Boehringer Ingelheim (speaker honoraria)
Novartis (speaker honoraria)